Eltrombopag in adult patients with immune thrombocytopenia in the real‐world in France, including off‐label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study. Issue 2 (6th December 2021) - Moulis, Guillaume; Germain, Johanne; Rueter, Manuela; Lafaurie, Margaux; Aroichane, Myriam; Comont, Thibault; Mahévas, Matthieu; Viallard, Jean‐François; Chèze, Stéphane; Ebbo, Mikaël; Audia, Sylvain; Leclerc‐Teffahi, Soraya; et al.